You searched for "learning"

822 results found

AvantSonic Z5 & Z3 bladder scanners

Real-time 3D automatic scanners, AvantSonic Z5 & Z3 measure bladder volume and PVR, producing fast and accurate measurements displayed on colour touch screens. Utilising advanced technology, AvantSonic Z5 & Z3...

AvantSonic Z5 & Z3 bladder scanners

Real-time 3D automatic scanners, AvantSonic Z5 & Z3 measure bladder volume and PVR, producing fast and accurate measurements displayed on colour touch screens. Utilising advanced technology, AvantSonic Z5 & Z3 are simple to...

BPS – a diagnostic enigma

This article from a London teaching hospital presents the results of a Medline search about challenges in bladder pain syndrome. All the known definitions from the American Urological Association (AUA), European Association of Urology (EAU), etc. are given while the...

Prostate Cancer UK: Towards Equity: Exploring Prostate Cancer Disparities Experienced by Black Men - data and evidence mini conference (Free)

We will delve into why Prostate Cancer UK is exploring health inequalities, starting with Black men and highlight valuable research findings and challenges in health inequalities space, with keynote speaker Dr Tom Cowling, who will share his insights from the latest England and Wales NPCA State of the Nation Report, including sociodemographic and tumour data from England. From 1.30 pm - 4.30pm

USANZ Trainee Week 2022 – a trip down under

The BAUS Section of Trainees (BSoT) opened applications for two senior UK urology trainees to be sponsored to attend the annual Urological Society of Australia and New Zealand (USANZ) Trainee Week, in Melbourne. The week is held in November each...

Update on immunotherapy for non-muscle invasive transitional cell carcinoma of the bladder

Patients with high-risk non-muscle invasive bladder cancer (NMIBC) that have failed Bacillus Calmette-Guérin (BCG) treatment are a difficult group to treat, and many may not be suitable for the preferred treatment option of radical cystectomy. Bladder-preserving treatments for BCG-unresponsive high-risk...

A greener urology

Healthcare in England is responsible for 4-5% of the country’s carbon footprint which is defined as the amount of greenhouse gasses, primarily carbon dioxide, released into the atmosphere by a particular activity. The six greenhouse gasses which vary in their...

Updated guide on integrated paediatric continence services to significantly improve children’s lives and save NHS cost

The Paediatric Continence Forum has recently launched its updated Guide on how to commission and run integrated, nurse-led, community-based paediatric bladder and bowel (continence) services. These are clinically effective, improve the lives of children and their families and generate significant...

USANZ Trainee Week 2024

It is our pleasure to report on our attendance at the Urological Society of Australia and New Zealand (USANZ) Trainee Week in Brisbane at the end of 2024. Firstly, we would like to thank The Urology Foundation, BSoT and BAUS...

The running gleet: why venereal disease is so important to the history of urology

In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). You might say that genitourinary infectious disease is a part of urology, but...

Menopause in Aesthetics 2025

Menopause in Aesthetics (MiA) returns for its highly anticipated third year! After two groundbreaking events, MiA 2025 promises to push the boundaries of aesthetic medicine and menopause care. This ever-evolving conference and exhibition puts you at the forefront of one...

First and second-line treatments in metastatic renal cell carcinoma

Over the past two decades, the treatment landscape for metastatic renal cell carcinoma (mRCC) has evolved significantly, leading to a quadrupling of patient survival rates. Modern systemic treatments include combinations of anti-PD-1 antibodies with either anti-CTLA-4 antibodies or antiangiogenic tyrosine...